Background Despite the improvement in the prognosis of acute coronary syndrome (ACS),
substantial morbidity and mortality remain. We aimed to evaluate the effect of obstructive …

Background To evaluate the safety of thiopurines in patients with inflammatory bowel
disease. To identify predictive factors associated with the development of thiopurine-induced …

Background. There is a lack of prospective studies evaluating the natural history of colonic
ischaemia (CI). We performed such a study to evaluate the clinical presentation, outcome, …

Background The efficacy of infliximab therapy in patients with Crohn's disease (CD) is
unknown beyond 12 months. For patients who lose their initial response, consideration can be …

… José Luis Cabriada José Luis Cabriada … José Luis Cabriada has received financial
support for travelling and educational activities from or has served as an advisory board …

(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe
the main epidemiological and clinical characteristics at diagnosis and the evolution of the …

Background & Aims There have been increasing reports of liver injury associated with use
of herbal and dietary supplements, likely due to easy access to these products and beliefs …

Background Recently, the notion that smoking may adversely affect Crohn′s disease ( CD
) outcomes has been challenged by the suggestion that the widespread use of …

Background Effectiveness of vedolizumab in real world clinical practice is unknown. Aim To
evaluate the short and long‐term effectiveness of vedolizumab in patients with inflammatory …

Background: Information on efficacy and predictors of response to adalimumab in ulcerative
colitis (UC) clinical practice is limited. Aim: Assessment of response to adalimumab and its …